Navigation Links
Surveyed Experts Indicate That Xarelto Has Advantages Over Lovenox in the Treatment of Venous Thromboembolism in Medically Ill Patients
Date:3/23/2009

Xarelto Will Earn Decision Resources' Clinical Gold Standard Status for VTE Prophylaxis in 2012, According to a New Report from Decision Resources

WALTHAM, Mass., March 23 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that surveyed cardiologists indicate that a therapy's effect on the prevention of venous thromboembolism (VTE) is the attribute that most influences their prescribing decisions for VTE prophylaxis in medically ill patients. Clinical data and the opinions of interviewed thought leaders indicate that Bayer/Johnson & Johnson's Xarelto has advantages in this attribute over Sanofi-Aventis's Lovenox, the sales-leading agent in the market.

The new report entitled Venous Thromboembolism Prophylaxis in Medically Ill Patients: Significant Opportunity Awaits Therapies Offering Improved Efficacy finds that an orally available therapy for VTE prophylaxis in medically ill patients would earn a 65 percent patient share in the United States and an 80 percent patient share in Europe, according to surveyed U.S. and European cardiologists.

In 2008, Decision Resources' proprietary clinical gold standard for VTE prophylaxis in medically ill patients was GlaxoSmithKline's Arixtra, owing largely to its efficacy. Based on available data and expert opinion, Xarelto will earn gold standard status for VTE prophylaxis in medically ill patients in 2012, following its approval for the indication in 2011.

"Xarelto has competitive advantages over Arixtra in terms of delivery and safety," said Decision Resources Analyst Christine Helliwell, Ph.D. "Xarelto's main advantage is that it causes a level of bleeding similar to that of Lovenox, whereas Arixtra suffers from a perception that it causes increased rates of bleeding over Lovenox."

About the Report

Venous Thromboembolis
'/>"/>

SOURCE Decision Resources
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Surveyed Oncologists Indicate that Avastin has Advantages over Temodar/Temodal in Increasing Overall Survival of High-Grade Glioma
2. As a Result of the Jupiter Trial, 65 Percent of Surveyed MCO Pharmacy Directors Will Reimburse Crestor for Patients with Elevated hsCRP
3. Less Than Two-Thirds of Surveyed Pharmacy Directors Expect to Reimburse Both Onglyza and Alogliptin Once They are Available for the Treatment of Type 2 Diabetes
4. Surveyed Gastroenterologists Indicate That Humira Has Advantages Over Remicade in Maintaining Clinical Remission of Crohns Disease
5. Half of Full-Time Employees Surveyed Dont Understand Health Insurance Coverage for Cancer-Related Medical Expenses
6. Surveyed Neurologists in Both the U.S. and Europe Would Welcome an Antiepileptic Drug That is Administered Once-Daily
7. Eighty-Nine Percent of Surveyed Rheumatologists Say They Will Prescribe Roche/Chugais Actemra for Rheumatoid Arthritis
8. World Vision Index of Concern: Half of Americans Surveyed Said They Would Be Willing to Pay More Taxes to Combat AIDS
9. Experts from Africa and Asia to Discuss Maternal Health in Live Online Chat
10. FDA Experts to Speak at RAPS Horizons Conference
11. In Hepatitis C Virus Treatment, Interviewed Experts Indicate That Telaprevir- and Boceprevir-Based Regimens Have Advantages Over Pegasys/Ribavirin in Sustained Virologic Response
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... May 27, 2015 According to research ... Southwestern Medical Center at Dallas some migraine patients have ... CTS and migraine headache apparently also have some shared ... of obesity, people with a history of diabetes and/or ... in Asians, and CTS in particular was less common ...
(Date:5/27/2015)... The Advanced Fertility Center of Chicago announces that their ... better serve the needs of couples in Chicagoland. The ... Northwest side of the city at 4920 North Central Ave., ... the Chicago office at (773) 794–1818. This is the ... The other 2 offices are in Gurnee and Crystal ...
(Date:5/26/2015)... Carey Danis & Lowe ... lawsuit . The suit pertains to AndroGel, a testosterone ... in late April 2015, and a court document relating ... court in mid-May.¹ , Testosterone gel lawsuits are being ... District of Illinois. The multidistrict litigation (MDL) is In ...
(Date:5/26/2015)... 2015 Securityhunter has been ... the United States Department of Health and Human Services ... The MATOC was awarded through the General Services Administration ... the PSC, which is a fee-for-service agency. The award ... options, and is an enterprise–wide physical security and security ...
(Date:5/26/2015)... (PRWEB) May 26, 2015 Forex Income ... interested in improving their results trading in the foreign ... trader Russ Horn, utilizes 10 customer indicators to help ... consistency. , "As usual, Russ Horn's latest trading system ... Forex trading community," reports Tiffany Hendricks, senior product reviewer ...
Breaking Medicine News(10 mins):Health News:Santa Rosa Orthopaedics Offers Insights into Recent Study Results Connecting Migraines with Chronic Conditions Such as Carpal Tunnel Syndrome 2Health News:Santa Rosa Orthopaedics Offers Insights into Recent Study Results Connecting Migraines with Chronic Conditions Such as Carpal Tunnel Syndrome 3Health News:Santa Rosa Orthopaedics Offers Insights into Recent Study Results Connecting Migraines with Chronic Conditions Such as Carpal Tunnel Syndrome 4Health News:The Advanced Fertility Center of Chicago Opens a New Fertility Office Location in Chicago 2Health News:Carey Danis & Lowe Comments on Recently Filed Testosterone Gel Lawsuit 2Health News:Securityhunter Has Been Awarded a Multiple Award Task Order Contract (MATOC) by the Department of Health and Human Services 2Health News:Forex Income Boss - Review Of Russ Horn's New FX Trading System Released 2
... Universities of Warwick, Edinburgh, Dundee and the Czech Republics ... compound that is up to 80 times more powerful ... light activation to kill cancer cells in much ... compound known as trans, trans, trans- [Pt(N3)2(OH)2(NH3)(py)], or ...
... Inc.,(Amex: PLC ) announced today that it has ... the way for the Company to begin,its initial launch ... to initiate a limited launch of RenalGuard(TM) in the ... recognize the benefits of,utilizing the unique fluid balancing capabilities ...
... HealthSouth,Corporation (NYSE: HLS ) announced today that its ... $16.25 per share on its 6.5%,Series A Convertible Perpetual ... record on January 2, 2008., About HealthSouth, ... Operating in 27 states across the country and in,Puerto ...
... The Greater Detroit Area Health,Council,s (GDAHC) ... partnership,with the American Diabetes Association, sanofi-aventis, and ... program to help people with,diabetes better manage ... connect,employers, community organizations and labor groups with ...
... linked, research suggests , FRIDAY, Dec. 21 (HealthDay News) -- ... diabetes, concludes a University of Pennsylvania School of Medicine study ... . , It found that providing depression care management to ... death over five years by about 50 percent. , "Depression ...
... Makes Results from Burdick(R) and, Quinton(R) branded products from Cardiac Science ... ... 5.0, BOTHELL, Wash. and MELVILLE, N.Y., ... provider of cardiac,monitoring, defibrillation and rehabilitative products, and Henry Schein,Medical Systems, ...
Cached Medicine News:Health News:Light powered platinum more targeted and 80 times more powerful than similar cancer treatments 2Health News:PLC Systems Receives CE Mark Approval for RenalGuard(TM) 2Health News:PLC Systems Receives CE Mark Approval for RenalGuard(TM) 3Health News:PLC Systems Receives CE Mark Approval for RenalGuard(TM) 4Health News:HealthSouth Declares Dividend on 6.5% Series A Convertible Perpetual Preferred Stock 2Health News:GDAHC Save Lives Save Dollars Initiative Launches Pilot Program for Diabetes Care Management 2Health News:GDAHC Save Lives Save Dollars Initiative Launches Pilot Program for Diabetes Care Management 3Health News:Cardiac Science Announces HeartCentrix(R) ECG Informatics Connectivity With Henry Schein Medical Systems' MicroMD(R) EMR 5.0 2Health News:Cardiac Science Announces HeartCentrix(R) ECG Informatics Connectivity With Henry Schein Medical Systems' MicroMD(R) EMR 5.0 3Health News:Cardiac Science Announces HeartCentrix(R) ECG Informatics Connectivity With Henry Schein Medical Systems' MicroMD(R) EMR 5.0 4Health News:Cardiac Science Announces HeartCentrix(R) ECG Informatics Connectivity With Henry Schein Medical Systems' MicroMD(R) EMR 5.0 5
(Date:5/26/2015)... 26, 2015  Haemonetics Corporation (NYSE: HAE ) ... Investor Relations, will present at The East Coast IDEAS ... June 4 th , 2015 at 2:30pm Eastern time.  ... presentation live via webcast at: http://www.wsw.com/webcast/threepa16/hae ... ) is a global healthcare company dedicated to providing ...
(Date:5/26/2015)... May 26, 2015   Mallinckrodt Pharmaceuticals (NYSE: ... announced that it has extended the deadline for submitting ... 31, 2015. The program awards grants to help fund ... The Mallinckrodt Research Fellowship Awards program is designed to ... The program will award a total of 25 positions. ...
(Date:5/26/2015)... 2015 Clinicient Inc , a ... the results of an industry survey of how ... therapists, practice owners and administrative staff completed the ... for technology and services that improve therapist efficiency. ... Clinicient published a free 12-page guide to help ...
Breaking Medicine Technology:Mallinckrodt Extends Deadline For 2015 Research Fellowship Program 2Mallinckrodt Extends Deadline For 2015 Research Fellowship Program 3Survey: Half of Physical Therapists Underbill For Their Services 2
... , , CLEVELAND, Dec. 15 At today,s ... (NYSE: LZ ), the board declared a regular quarterly ... holders of record at the close of business on February 10, ... Corporation (NYSE: LZ ) is an innovative specialty chemical ...
... , BATESVILLE, Ind., Dec. 15 Today, Hill-Rom Holdings, Inc. ... on significant strategic and financial initiatives at its Investor Conference ... Peter H. Soderberg, president and CEO of Hill-Rom, and will ... multi-year strategic initiatives Business unit, research and development and ...
Cached Medicine Technology:Lubrizol Declares Dividend 2Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 2Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 3Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 4Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 5Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 6Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 7
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size....
Medicine Products: